5th Edition Drug Pricing Transparency Congress

September 18-19, 2019 | USA

In light of recent focus on HHS’s proposal to eliminate rebates, the Senate Finance hearing with Pharma CEOs, and a strong legislative movement towards transparency, there is a heightened focus on drug pricing transparency in the United States. Recent federal and state rulings create lingering questions around legislation and compliance complexities that will impact the market in real-time causing uncertainty.

Spotlight

Via America’s Lawyer: Mike Papantonio and Truth In Media’s investigative journalist Ben Swann examine the revolving door phenomenon between the FDA and pharmaceutical companies. The government has capped funding for the FDA, meaning capped salaries for regulators working there. Drug companies are capitalizing on this by offering MASSIVE salaries as a means of buying influence among FDA staff responsible for approving new drugs in an all-out bidding war.


OTHER PAST CONFERENCES

Pharmaceutics And Novel Drug Delivery Systems

June 13-14, 2022 | Italy

The pharmaceutical sector plays a central role in the development and design of drugs and vaccines. Pharma innovation advanced at an astounding rate in the last year to combat the COVID-19 pandemic.

1st Annual Psychedelic Therapeutics and Drug Development Conference

May 23-24, 2022 | USA

1st Annual Psychedelic Therapeutics and Drug Development Conference in 2021, we're thrilled to be hosting the 2nd Annual event on May 23-24, 2022 in Washington, DC.

3rd European Congress on Pharmaceutical Science And Research

August 15-16, 2022 | Singapore

PHARMACEUTICAL SCIENCE 2022 welcomes attendees, presenters, and exhibitors from all over the world to Singapore. We are delighted to invite you all to attend and register for the “3rd European Congress on Pharmaceutical Science & Research” which is going to be held during August 15-16, 2022 in Singapore.

DEVELOPMENT OF NEXT-GENERATION VACCINES ONLINE SUMMIT

June 8-9, 2022 | USA

With an unprecedented acceleration in vaccine development seen over the past two years, the spotlight is now focused on the next generation of vaccines. Drug Target Review‘s new online summit will cover all the latest innovation in vaccine development.

Spotlight

Via America’s Lawyer: Mike Papantonio and Truth In Media’s investigative journalist Ben Swann examine the revolving door phenomenon between the FDA and pharmaceutical companies. The government has capped funding for the FDA, meaning capped salaries for regulators working there. Drug companies are capitalizing on this by offering MASSIVE salaries as a means of buying influence among FDA staff responsible for approving new drugs in an all-out bidding war.

resources